17 min

Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease JAMA Neurology Author Interviews

    • Medicine

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

  • American Medical Association, 2020

Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials

17 min

  • American Medical Association, 2020

More by JAMA Network

JAMA Clinical Reviews
JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Medical News
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMA Pediatrics Editors' Summary
JAMA Pediatrics Editors' Summary
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Psychiatry Author Interviews
JAMA Network
JAMA Neurology Author Interviews
JAMA Neurology Author Interviews
JAMA Network